Immunogenicity and Safety of COVID-19 mRNA Vaccine in STAT1 GOF Patients

被引：9
|
作者：
Bloomfield, Marketa [1 ,2 ,3 ,4 ]
Parackova, Zuzana [1 ,2 ]
Hanzlikova, Jana [5 ,6 ]
Lastovicka, Jan [1 ,2 ]
Sediva, Anna [1 ,2 ]
机构：
[1] Charles Univ Prague, Fac Med 2, Dept Immunol, V Uvalu 84, Prague 15006, Czech Republic
[2] Univ Hosp Motol, V Uvalu 84, Prague 15006, Czech Republic
[3] Charles Univ Prague, Fac Med 1, Dept Pediat, Prague, Czech Republic
[4] Thomayer Univ Hosp, Prague, Czech Republic
[5] Charles Univ Prague, Dept Immunol & Allergol, Fac Med, Plzen, Czech Republic
[6] Charles Univ Prague, Fac Hosp Pilsen, Plzen, Czech Republic
来源：
JOURNAL OF CLINICAL IMMUNOLOGY | 2022年 / 42卷 / 02期
关键词：
D O I：
10.1007/s10875-021-01163-8
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：266 / 269
页数：4
相关论文
共 50 条
  • [1] Immunogenicity and Safety of COVID-19 mRNA Vaccine in STAT1 GOF Patients
    Marketa Bloomfield
    Zuzana Parackova
    Jana Hanzlikova
    Jan Lastovicka
    Anna Sediva
    Journal of Clinical Immunology, 2022, 42 : 266 - 269
  • [2] Safety and immunogenicity of mRNA COVID-19 vaccine in inpatients with muscular dystrophy
    Saito, Tomoko
    Saito, Toshio
    Hashimoto, Hiroya
    Ogata, Katsuhisa
    Kobayashi, Michio
    Takada, Hiroto
    Kuru, Satoshi
    Kimura, Takashi
    Nakamura, Akinori
    Matsumura, Tsuyoshi
    MUSCLE & NERVE, 2023, 67 (02) : 117 - 123
  • [3] The safety and immunogenicity to inactivated COVID-19 vaccine in patients with hyperlipemia
    Yang, Lei
    Liu, YaMing
    Guo, Qiao
    Jiang, DePeng
    OPEN MEDICINE, 2023, 18 (01):
  • [4] COVID-19 mRNA vaccine safety, immunogenicity, and effectiveness in a hospital setting: confronting the challenge
    Sultana, Janet
    Caci, Grazia
    Hyeraci, Giulia
    Albano, Luciana
    Gianfredi, Vincenza
    INTERNAL AND EMERGENCY MEDICINE, 2022, 17 (02) : 325 - 327
  • [5] COVID-19 mRNA vaccine safety, immunogenicity, and effectiveness in a hospital setting: confronting the challenge
    Janet Sultana
    Grazia Caci
    Giulia Hyeraci
    Luciana Albano
    Vincenza Gianfredi
    Internal and Emergency Medicine, 2022, 17 : 325 - 327
  • [6] Immunogenicity, safety and efficacy of COVID-19 vaccine: Correspondence
    Mungmunpuntipantip, Rujittika
    Wiwanitkit, Viroj
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2023, 45
  • [7] Safety and Immunogenicity of Homologous and Heterologous Adenoviral-Vectored and mRNA COVID-19 Vaccine Regimens in Radiotherapy Patients
    Prayongrat, Anussara
    Noppaving, Patjaya
    Chobarporn, Thitiporn
    Sudhinaraset, Natthinee
    Teeyapun, Nattaya
    Pakvisal, Nussara
    Jantarabenjakul, Watsamon
    Sophonphan, Jiratchaya
    Lertbutsayanukul, Chawalit
    Poovorawan, Yong
    VACCINES, 2023, 11 (07)
  • [8] The immunogenicity, reactogenicity, and safety of a bivalent mRNA or protein COVID-19 vaccine given as a fourth dose
    Mazarakis, Nadia
    Toh, Zheng Quan
    Neal, Eleanor
    Bright, Kathryn
    Luu, Skyy
    Quah, Leanne
    Ng, Yan Yung
    Nguyen, Cattram
    Hart, John
    Do, Lien Anh Ha
    Rudel, Anna
    Dassanayake, Shashini
    Higgins, Rachel A.
    Ong, Darren Suryawijaya
    Justice, Fran
    Moore, Kerryn A.
    Watts, Emma
    Mahanty, Siddhartha
    Subbarao, Kanta
    Mulholland, Kim
    von Mollendorf, Claire
    V. Licciardi, Paul
    JOURNAL OF INFECTION, 2025, 90 (03)
  • [9] Safety of a mRNA COVID-19 Vaccine in Patients with Indolent Systemic Mastocytosis
    Gouveia, Joana
    Rodrigues, Maria Alexandra
    Fernandes, Iolanda
    Cabral, Renata
    Falcao, Helena
    ACTA MEDICA PORTUGUESA, 2024, 37 (03) : 224 - 225
  • [10] The safety and immunogenicity of inactivated COVID-19 vaccine in old pulmonary tuberculosis patients
    Yang, Lei
    Xiang, Feng
    Wang, Dian
    Guo, Qiao
    Deng, Bing
    Jiang, DePeng
    Ren, Hong
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2023, 42 (04) : 503 - 512
12345